Oxford Biomedica (OXB) logo

Senior Scientist, Lead Analytical Development Operations

Oxford Biomedica (OXB)

Bedford, MAOnsitePosted 9 days ago
Full TimeSenior LevelResearch & ScientistCDMO
Original posting ↗

Summary

Reporting to the Vice President of Development Services, the purpose of the role is providing scientific and operational leadership for analytical method development operations and systems, qualification, transfer, and lifecycle management supporting viral vector process development and GMP manufacturing programs.

Job description

Responsibilities

  • Lead analytical development operations including status of client work, FTE, Cost model, material inventory and ensure Analytical team members write protocols and generate reports related to QC Method transfer, validation, and verification activities
  • Support qualification, transfer, validation, and verification of GMP analytical methods including but not limited to ddPCR, qPCR, ELISA, HPLC, Capillary electrophoresis (CE-SDS), LCMS, Cell-based Assays (e.g. TCID50, Gene expression, flow cytometry, and Potency)
  • Serve as subject matter expert during client meetings, project reviews, tech transfer discussions as well as build client relationships and support business development opportunities as needed
  • Support monitoring of on-going analytical method performance (e.g. system suitability trending) to drive continued improvement and optimization of OXB's analytical methods
  • Assist with data trending of assay controls and reference standards, as needed
  • Lead and support analytical troubleshooting, as needed
  • Partners with internal and cross-functional departments (e.g. QC, Internal QA, External QA) to ensure success of analytical services program
  • Presentation to cross-functional teams and effectively communicate critical analytical issues and solutions
  • Mentor and develop associates and scientists in analytical development

Qualifications

  • Bachelor's degree in biology, Chemistry or equivalent; advanced degree preferred
  • 10+ years of related experience post-degree
  • Proven ability to lead cross-functional teams and client-facing technical discussions
  • Extensive experience in analytical method development, qualification and tech transfers
  • Demonstrated expertise in analytical method development supporting viral vectors for gene therapy
  • Knowledge of quality principles and GMP, ICH and GLP regulations
  • Familiarity with HPLC, AUC, CE-SDS, ELISA, ddPCR, qPCR and Cell based assays
  • Experience creating/revising/reviewing operational SOPs, technical documents, protocols, and reports

Requirements

  • Bachelor's degree in biology, Chemistry or equivalent
  • 10+ years of related experience post-degree
  • Proven ability to lead cross-functional teams and client-facing technical discussions
  • Extensive experience in analytical method development, qualification and tech transfers
  • Demonstrated expertise in analytical method development supporting viral vectors for gene therapy
  • Knowledge of quality principles and GMP, ICH and GLP regulations
  • Familiarity with HPLC, AUC, CE-SDS, ELISA, ddPCR, qPCR and Cell based assays
  • Experience creating/revising/reviewing operational SOPs, technical documents, protocols, and reports
  • Eligible to work in the United States

Benefits

  • Competitive total reward packages
  • Wellbeing programs
  • Career development opportunities
  • Supportive, inclusive culture
  • State-of-the-art labs

Company overview

Oxford Biomedica (OXB) is a global quality and innovation-led contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. Founded in 1995 as a spin-out from the University of Oxford, the company has over 30 years of experience in viral vector technology, which serves as the driving force behind most cell and gene therapies. OXB collaborates with leading pharmaceutical and biotechnology companies worldwide, providing comprehensive viral vector development and manufacturing expertise across lentivirus, adeno-associated virus (AAV), adenovirus, and other viral vector types. The company operates a global network of facilities across Oxfordshire (UK), Lyon and Strasbourg (France), Bedford MA (US), and Durham NC (US), offering end-to-end capabilities from early-stage development through commercialization. As a publicly traded company listed on the London Stock Exchange (LSE: OXB) and a constituent of the FTSE 250 Index, OXB has established itself as a pioneer in advanced therapies, having been the first commercial supplier of lentiviral vectors for CAR-T therapy and the first company to treat patients in-vivo with lentiviral vector gene therapy.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.